吉利德概念走強 永太科技、博騰股份漲停
格隆匯4月17日丨3期臨牀試驗顯示瑞德西韋效果顯著,A股市場吉利德概念股走強,其中,永太科技、博騰股份漲停,博瑞醫藥漲近5%,海南海藥漲4%,藥明康德和九州藥業均有所上漲。
芝加哥大學的3期臨牀試驗發現,在使用了該公司抗病毒藥物瑞德西韋后,大多數患者發燒和呼吸道症狀均迅速好轉,並在不到一週的時間內出院。公司預計四月底將得到針對新冠肺炎重症患者的第三期數據。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.